SSE Ticker: 600329

Tianjin Zhongxin Pharmaceutical Group Corporation Ltd.

中新药业

Authorized Representative: 李立群

Board: Main A

Industry Classification: Manufacturing

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

Post date May 16, 2022 — 08:44 Post Lock

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

Post date May 10, 2022 — 10:07 Post Lock

Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery

Post date May 6, 2022 — 22:37 Post Lock

The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry

Post date May 6, 2022 — 18:35 Post Lock

Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball

Post date May 3, 2022 — 18:04 Post Lock

What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code)

Post date May 2, 2022 — 11:17 Post Lock

45 stocks received institutional buy ratings today, 12 stocks rose more than 20%_Oriental Fortune Network

Post date April 29, 2022 — 19:37 Post Lock

The balance of the two financing and financing has shrunk by 8.798 billion yuan, and the leveraged funds have increased significantly by 64 shares.

Post date April 28, 2022 — 15:43 Post Lock

Changsheng Emerging Growth Mixed Net Worth Down 4.53%

Post date April 26, 2022 — 07:02 Post Lock

Changsheng Internet + mixed net worth fell 4.64%_Sina Finance_Sina.com

Post date April 26, 2022 — 06:56 Post Lock

4.525 billion yuan of funds flowed out of pharmaceutical and biological stocks today – yqqlm

Post date April 25, 2022 — 18:15 Post Lock

Pharmaceutical Industry Weekly Report: Short-term irrational sadness in medicine, long-lasting can be more joyful, postal courier tracking number, postal courier inquiry, postal courier parcel inquiry, postal courier parcel inquiry

Post date April 24, 2022 — 15:31 Post Lock

Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be doubled in the medium and long term.

Post date April 24, 2022 — 15:31 Post Lock

Pharmaceutical Industry Weekly Report: Short-term irrational pessimism in medicine can be more optimistic in the medium and long term

Post date April 24, 2022 — 15:31 Post Lock

2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year.

Post date April 18, 2022 — 13:42 Post Lock

Pien Tze Huang: The cost of drugs for liver disease, the mainstay of revenue, has grown, and the gross profit has dropped slightly, and the core strategy of changing the chairman twice a year has been adjusted.

Post date April 18, 2022 — 13:25 Post Lock

Financiers are optimistic about the purchase of 6 shares, accounting for over 30% of the transaction_ Oriental Fortune Net

Post date April 14, 2022 — 14:22 Post Lock

[Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it.

Post date April 12, 2022 — 19:23 Post Lock

Financiers are optimistic about the purchase of 3 shares, accounting for over 30% of the transaction_ Oriental Fortune Net

Post date April 12, 2022 — 10:55 Post Lock

Pharmaceutical Industry Weekly Report: The 14th Five-Year Plan of Traditional Chinese Medicine is strategically optimistic in 2022_Oriental Fortune Net

Post date April 7, 2022 — 15:09 Post Lock

Want to see more data? Registered subscribers can see all the data.